Delivery Order SPE2DB22D2006-SPE2DB24FW1SA

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,596.53, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The ceiling value of this firm-fixed-price delivery order is $16,378.05, with an ultimate completion date of August 19, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is part of Amerisourcebergen's larger...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $5,340.35. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S to the Defense Logistics Agency (DLA), a major defense agency. The $3,441.74 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor and healthcare solutions provider, on December 9, 2024, with a completion date of December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $2,596.53 and is a firm-fixed-price delivery order. It does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,546.44 and is a firm fixed-price delivery order with an ultimate completion date of December 12, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Medical Supply Chain of the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $18,531.20 and an ultimate completion date of May 6, 2024. The contract is a delivery order, with a firm fixed-price pricing type, and was...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,133.59 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024. The contract has an ultimate completion date of December 11, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,828.40 and an Ultimate Completion Date of January 23, 2025. The contract was awarded on January 22, 2025 and does not have a set-aside...
This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $8,978.36 and is a firm fixed-price delivery order with an ultimate completion date of January 12, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1SA
    Delivery Order

This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and has a ceiling value of $3,439.65.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 10/7/24, 10:39 AM